Johanna Risse
Biographic Data
| ID | 4620435 |
|---|---|
| NAME | Johanna Risse |
| GIVEN NAMES | Johanna |
| FAMILY NAME | Risse |
| SIGNATURE | RISSE J |
| AFFILIATIONS | University of Bonn |
| ORCID | 0000-0002-6766-4309 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Snip, snip, cure”? Philosophical, legal and biomedical perspectives on novel somatic genomic therapies
The advent of innovative techniques, such as the CRISPR/Cas system, has opened up a new range of possibilities for modifying the genome, with the potential to address previously unmet therapeutic needs of patients with genetic diseases. These new possibilities have not only raised ethical concerns but also challenged existing classifications of genome modification techniques. While the legal status of some of these new therapies remains uncertain…
Dying like a dog
Standard views of good death in human and veterinary medicine considerably differ from one another. Whereas the good death ideal in palliative medicine emphasizes the positive aspects of non-induced dying, veterinarians typically promote a quick and painless killing with the aim to end suffering. Recent developments suggest a convergence of both professions and professional attitudes, however. Palliative physicians are confronted with patients wi…
No prominent works on this page.
Dying like a dog
Standard views of good death in human and veterinary medicine considerably differ from one another. Whereas the good death ideal in palliative medicine emphasizes the positive aspects of non-induced dying, veterinarians typically promote a quick and painless killing with the aim to end suffering. Recent developments suggest a convergence of both professions and professional attitudes, however. Palliative physicians are confronted with patients wi…
Snip, snip, cure”? Philosophical, legal and biomedical perspectives on novel somatic genomic therapies
The advent of innovative techniques, such as the CRISPR/Cas system, has opened up a new range of possibilities for modifying the genome, with the potential to address previously unmet therapeutic needs of patients with genetic diseases. These new possibilities have not only raised ethical concerns but also challenged existing classifications of genome modification techniques. While the legal status of some of these new therapies remains uncertain…
Alternative medicine (2 works) · Epistemology (2 works) · Medical law (2 works) · Medicine (2 works) · Philosophy of medicine (2 works) · Analogy (1 work) · Animal welfare (1 work) · Artificial Intelligence (1 work) · Biology (1 work) · Biomedical Ethics and Regulation (1 work)